Anethole

Quick links to important sections

Anethole

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Anethole

Property Description
Active ingredient Anetholtrithione (ATT)
Form Coated tablet (Oral)
Pharmacological class Choleretic drug, Sialogogue
Common purpose Stimulation of bile and saliva flow
Origin Synthetic compound

Anetholtrithione is a chemically defined, synthetic compound used as a pharmaceutical agent, often recognized by the acronym ATT or the synonym Anethole trithione. This substance is classified chemically as a substituted dithiolthione, an organosulfur compound whose identity is confirmed by the molecular formula C10H8OS3. Unlike the Anethole from which it is derived—a naturally occurring component found in essential oils like anise oil—Anetholtrithione is a highly specific, laboratory-prepared derivative, ensuring consistent purity and predictable medicinal activity. The World Health Organization's Anatomical Therapeutic Chemical (ATC) classification system designates it under the code A16AX02, grouping it with miscellaneous alimentary tract products.

Composition, Form, and General Therapeutic Purpose

The drug’s core mechanism defines its two primary pharmacological roles: it functions as a choleretic drug and a sialogogue. The term choleretic signifies its ability to stimulate the production and flow of bile from the liver, while sialogogue refers to its action in increasing the secretion of saliva. This dual glandular action is supported by pharmacological studies which have clinically recognized Anetholtrithione for its efficacy in stimulating salivary output. Anetholtrithione is primarily manufactured for oral delivery as a coated tablet, a solid pharmaceutical preparation designed for systematic absorption. This dual classification dictates its overall purpose: to address conditions arising from the insufficient secretion of these specific exocrine fluids, thereby supporting both digestive function via bile flow and lubrication via saliva flow, which is a common therapeutic goal for patients experiencing persistent dry mouth (xerostomia).

What side effects are possible with Anethole?

Possible Side Effects and Safety Information

The safety profile for Anetholtrithione (ATT) focuses on officially documented adverse reactions and specific usage restrictions as defined in regulatory texts. Adverse reactions are grouped according to the physiological systems affected, a classification standard used by regulatory agencies.

System-Organ Classification of Adverse Reactions

Adverse reactions associated with Anetholtrithione primarily involve the following system-organ classes:

  • Gastrointestinal Disorders: These effects include common forms of digestive discomfort, such as nausea, abdominal pain, flatulence, and diarrhea. The label also notes softening of stool as an anticipated change.
  • Renal and Urinary Disorders: A frequently reported and generally non-pathological effect is the occurrence of dark urine (chromaturia).
  • Nervous System Disorders: Reactions documented in this class include headache, fatigue, and occasional reports of drowsiness or dizziness.
  • Immune System Disorders: Potential allergic reactions (hypersensitivity) are listed, which are monitored as a clinically significant safety concern.

Serious Safety Restrictions and Special Populations

The official prescribing information establishes clear safety limitations for the use of this medicine. Anetholtrithione is strictly contraindicated and must not be used in individuals with a known, pre-existing diagnosis of biliary tract obstruction, as this condition presents a serious risk boundary.

Regulatory documentation also mandates caution concerning specific populations. Use is generally not advised for individuals who are pregnant or breastfeeding due to a lack of sufficient safety data. Furthermore, patients with severe liver or renal impairment require close supervision and caution, as the drug's metabolism and excretion may be altered, potentially leading to increased systemic exposure.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Anetholtrithione overdose is primarily defined by the product’s documented acute toxicity classification and the resultant mandatory emergency response.

Category Official Regulatory Statement
Documented Manifestations No specific human clinical symptoms of acute overdose, distinct from common adverse effects, are publicly detailed in accessible regulatory summaries.
Severity Classification The substance is officially classified in government documents as Harmful if swallowed, reflecting an officially documented hazard for acute oral toxicity.
Antidote Information No specific antidote for Anetholtrithione overdose is documented in official prescribing information.

Mandatory Emergency Action

In the event of suspected or confirmed ingestion of an excessive quantity of Anetholtrithione, regulatory guidance requires individuals to seek immediate medical attention. This includes contacting emergency services or a poison control center, an action mandated by the substance’s official acute toxicity classification and the potential for severe outcomes.

Management in an overdose context is restricted to established toxicology procedures involving symptomatic and supportive treatment. Emergency department evaluation and observation are required following the official instruction to seek urgent medical care. This approach is necessary because specific reversal agents are not documented in the regulatory profile, and no population-specific overdose considerations are explicitly outlined in the official documentation.

Therapeutic Uses of Anethole

Main Uses and Benefits of Anethole

Anethole is a phenylpropene derivative that serves as the primary aromatic component in essential oils derived from plants such as star anise, fennel, and anise. In therapeutic contexts, it is valued for its specific pharmacological properties, particularly within the gastrointestinal and respiratory systems.

Gastrointestinal Support

The most common application of anethole is the management of digestive discomfort. It is classified as a carminative, a substance that helps prevent the formation of gas in the digestive tract or facilitates its expulsion.

  • Reduction of Flatulence: Anethole helps relax the smooth muscles of the intestines, which can alleviate the pressure and bloating associated with gas.
  • Antispasmodic Effects: By reducing muscle spasms in the digestive tract, it may help soothe abdominal cramping and discomfort related to indigestion.

Respiratory Relief

Anethole is frequently utilized in the management of upper respiratory conditions due to its secretolytic and expectorant properties.

  • Mucus Clearance: It helps thin and loosen respiratory secretions, making it easier for the body to clear mucus from the airways.
  • Cough Support: Its soothing effect on the mucous membranes can provide relief from the irritation that triggers coughing fits associated with the common cold or mild bronchitis.

Antimicrobial and Antioxidant Properties

Research into the chemical profile of anethole has identified secondary benefits that support its traditional use in health maintenance:

  • Antimicrobial Activity: Anethole exhibits activity against certain types of bacteria and fungi, which may contribute to maintaining a balanced internal environment.
  • Antioxidant Action: It possesses the ability to neutralize free radicals, potentially protecting cells from oxidative stress and supporting overall physiological stability.

Eligibility and Restrictions for Use

Anethole is the primary aromatic compound in anise and fennel, and while generally recognized as safe (GRAS) in food amounts, medicinal use or concentrated forms require caution, particularly for certain populations.

Potential Contraindications

  • Pregnancy and Breastfeeding: Use in amounts exceeding those found in typical food is not recommended due to limited safety data. Anethole is excreted in breast milk, and excessive maternal consumption of anise/fennel-containing teas has been linked to toxicity in newborns (lethargy, weak cry, poor sucking).
  • Hormone-Sensitive Conditions: Anethole may act as a phytoestrogen. Individuals with estrogen-dependent cancers (such as certain breast, uterine, and ovarian cancers) or conditions like endometriosis should avoid using Anethole in medicinal quantities.
  • Allergies: People with known allergies to other plants in the Apiaceae family—including celery, carrot, caraway, coriander, cumin, dill, and fennel—may experience allergic reactions to Anethole.

Drug Interactions and Precautions

Condition / Drug Class Potential Interaction or Caution
Antidiabetes Drugs May lower blood sugar; monitor glucose levels closely to prevent hypoglycemia.
Estrogen Medications May alter the effects of estrogen-containing drugs, including some birth control pills and hormone replacement therapies.
Tamoxifen May decrease the effectiveness of tamoxifen due to its estrogenic activity.
Surgery Stop use at least two weeks prior to a scheduled surgery, as it might interfere with blood sugar control.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory interaction profile for Anetholtrithione (ATT) is characterized by the absence of specific, formally documented interaction warnings or restrictions typically found in prescribing information. Analysis of authoritative governmental summaries confirms that no medicinal products are formally classified as contraindicated for co-administration with ATT. Furthermore, the regulatory labels do not document any mandatory timing requirements to separate the administration of Anetholtrithione from other medicines.

Regarding potential metabolic interactions, official regulatory summaries state that the specific Cytochrome P450 (CYP) isoforms involved in the metabolism of Anetholtrithione are not formally elucidated. Consequently, the official profile does not contain specific warnings regarding interactions that could alter drug exposure through enzyme inhibition or induction. No specific drug-transporter or pharmacodynamic interactions are formally classified or documented in official regulatory labeling.

This profile, defined by the lack of specific documented entities, extends to other substances, as no formal restrictions are documented regarding concurrent consumption with food, alcohol, or specific herbal products. This structure reflects the current official regulatory definition of the product’s interaction profile.

Mechanism of Action

Anethole is an organic molecule that exerts its physiological effects primarily through the modulation of ion channels and intracellular signaling pathways within excitable tissues.

The molecule acts as a positive allosteric modulator of the GABAA receptor, which is a ligand-gated chloride ion (Cl^-) channel. This interaction enhances the inhibitory effect of the endogenous neurotransmitter gamma-aminobutyric acid (GABA), increasing the frequency of channel opening and thus promoting the influx of chloride ions into the neuron. This leads to neuronal hyperpolarization, consequently reducing the excitability and firing rate of targeted central nervous system (CNS) neurons. Concurrently, anethole interacts with certain voltage-gated calcium channels and potassium channels in peripheral cells. By influencing calcium flux across the membrane, anethole modulates the activity of key enzymes, such as myosin light-chain kinase, a process integral to regulating the contractile state of smooth muscle tissue. The combined effect of enhanced CNS inhibition and altered peripheral ion channel dynamics results in a generalized decrease in central nervous system activity and modulation of involuntary smooth muscle tone.

Dosage and Administration Information

The administration of Anetholtrithione is oral, utilizing a coated tablet formulation offered in 12.5 mg and 25 mg strengths. The dosage and specific timing ensure adherence to the administration protocol.

Administration Parameter Instructions
Standard Adult Dosing 25 mg taken three times daily (TID).
25 mg Tablet Timing To be administered with meals.
12.5 mg Tablet Timing To be administered about 30 minutes before meals.
Route of Administration Oral (swallowed by mouth).

The medication follows a fixed, three-times-daily frequency, with the dosage consumed in direct relation to mealtimes, an instruction that varies based on the tablet strength used. For the pediatric population, specific low-dose schedules based on the 12.5 mg strength are outlined for children aged 6 to 15 years, typically starting at two to three tablets per day, but use is not established for children under six years of age. Treatment with Anetholtrithione follows this consistent daily schedule, as the full therapeutic effect is gradual and may not be apparent until after several days of continuous administration. The dosage may be subject to adaptation based on the individual’s response to the established regimen.

Recent Clinical Evidence

Anethole: Recent Clinical Evidence

Research has explored the properties and potential applications of Anethole, a naturally occurring organic compound. Anethole is the primary component of the essential oils derived from anise and fennel.

Scientific Investigation and Study Focus

Studies have investigated whether Anethole may influence specific biological pathways in laboratory and preclinical models. Research interest is often directed toward its antioxidant and antispasmodic properties, primarily examined in in vitro (cell-based) and animal models.

One primary study evaluated the inhibition of lipid peroxidation in specific in vitro systems, suggesting that Anethole may demonstrate antioxidant behavior by supporting cellular structures against damage. The scope of this research does not currently extend to clinical conclusions in humans.

Analgesic and Anti-inflammatory Evaluation

Limited research has explored the relationship between Anethole administration and discomfort levels in animal studies. These investigations primarily evaluate metrics such as response time to thermal stimuli and the reduction of chemically induced edema (swelling) in rodents. The objective of such animal studies is to determine if the compound has properties that warrant further, more rigorous investigation. Current evidence does not support claims of therapeutic benefit or efficacy in humans for pain or inflammation relief.

Gastrointestinal System Research

Certain studies have focused on Anethole's influence on smooth muscle activity, which may relate to its traditional use in managing mild digestive discomfort. Research protocols have included the measurement of motility patterns in isolated intestinal tissues. The scope of the current research does not fully clarify Anethole's role in managing specific human gastrointestinal conditions, and clinical research in this area remains limited.

Frequently Asked Questions (FAQ)

Common questions about Anethole (FAQ)

Q: What is Anethole?

Anethole is an organic compound that is the main component of the essential oils of anise, fennel, and star anise. It is a type of phenylpropene, an aromatic compound that is structurally related to chemicals like eugenol and estragole.

Q: What is Anethole typically used for?

Anethole is widely used as a flavoring agent in food, beverages, and confectionery, providing a characteristic sweet, licorice-like taste. It is also used as a fragrance ingredient in perfumes, soaps, and dental products. In traditional medicine, plants containing anethole have been used to address digestive issues and as an expectorant.

Q: How does Anethole affect the body?

Anethole is known to interact with various systems in the body. Research suggests it has antioxidant properties, which may help protect cells from damage caused by free radicals. It may also have anti-inflammatory effects and has been observed to interact with certain neurotransmitter receptors, such as GABA-A receptors, which could contribute to its reported calming effects in traditional uses.

Q: Is Anethole safe to consume?

Anethole is generally recognized as safe (GRAS) by the U.S. Food and Drug Administration (FDA) for use as a food additive and flavoring when consumed at levels typically found in food. However, consuming large quantities of pure anethole or highly concentrated essential oils containing it may lead to adverse effects. The safety of anethole depends on the concentration and method of exposure.

Q: Are there any known side effects or contraindications for Anethole?

When consumed in normal dietary amounts, anethole is usually well-tolerated. High doses, however, might cause side effects such as:

  • Nausea or vomiting
  • Skin irritation or allergic reactions in sensitive individuals, especially with topical application

People with hormone-sensitive conditions (like certain cancers or endometriosis) should use products containing concentrated anethole with caution, as some studies suggest it may have mild estrogenic effects. Pregnant or breastfeeding individuals should consult a healthcare provider before using high-dose supplements or essential oils containing anethole.

How should Anethole be stored and disposed of?

The required storage and disposal conditions for Anethole as a pharmaceutical ingredient are governed by authoritative standards, such as the United States Pharmacopeia (USP), which ensures its quality and stability.

Storage & disposal scope

Labeled storage temperature requirements: Store in a cool, dry, and well-ventilated area, away from heat sources.
Light/moisture protection requirements: Preserve in tight, light-resistant containers.
Stability after opening/reconstitution (if applicable): Not defined in the USP monograph.
Handling requirements: Keep container tightly closed and store away from incompatible materials, sparks, and open flames.
Packaging-related storage rules (if applicable): Preserve in tight, light-resistant containers (USP requirement).
Disposal instructions (as documented in government sources): Dispose of contents and container in accordance with local, regional, national, and international regulations.
Environmental or controlled-waste disposal requirements (if applicable): Avoid release to the environment; do not let the product enter drains or surface water.
Child-protection storage requirements (if stated): Not explicitly stated in the USP monograph.

Resulting storage & disposal structure

Official storage and disposal statements:

  • Preserve in tight, light-resistant containers to maintain the stability of the ingredient.
  • Avoid release to the environment and do not let the product enter drains.
  • Dispose of contents and container in accordance with applicable local, regional, and national regulations for chemical waste.

The official profile dictates that Anethole must be stored in specialized containers to prevent degradation from moisture and light. Furthermore, regulatory mandates require the product to be handled and disposed of as chemical waste, with a specific instruction to protect the environment and water sources.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Anethole found in:

A-Z Index: